市场调查报告书

中风的诊断和治疗 - 全球市场的未来展望(2017-2026)

Stroke Diagnostics and Therapeutics - Global Market Outlook (2017-2026)

出版商 Stratistics Market Research Consulting 商品编码 521463
出版日期 内容资讯 英文 188 Pages
商品交期: 2-3个工作天内
价格
中风的诊断和治疗 - 全球市场的未来展望(2017-2026) Stroke Diagnostics and Therapeutics - Global Market Outlook (2017-2026)
出版日期: 2018年08月01日内容资讯: 英文 188 Pages
简介

全球中风的诊断和治疗市场2017年是238亿4,939万美金。今后预计以8.5%的年复合成长率扩大,2026年达到496亿9,868万美元。

本报告提供中风的诊断和治疗的全球市场调查,市场概要,各类型、用途、地区的市场趋势,市场规模的变化与预测,市场促进、阻碍因素以及市场机会分析,竞争情形,主要企业的简介等全面性资讯。

目录

第1章 摘要整理

第2章 简介

第3章 市场趋势分析

  • 简介
  • 成长要素
  • 阻碍因素
  • 市场机会
  • 威胁
  • 应用分析
  • 新兴市场
  • 今后的市场情况

第4章 波特的五力分析

  • 供应商谈判力
  • 买方议价能力
  • 替代品的威胁
  • 新加入厂商的威胁
  • 产业内的竞争

第5章 中风的诊断和治疗市场:各类型

  • 简介
  • 诊断
    • MRI
    • 电脑断层扫描
    • 心电图
    • 颈动脉超音波
    • 脑血管造影术
    • 其他
  • 治疗方法
    • 组织型胞浆素原活性化因子
    • 抗血小板药疗法
    • 降压剂疗法
    • 抗凝固疗法

第6章 中风的诊断和治疗市场:各用途

  • 简介
  • 出血性
  • 缺血性

第7章 中风的诊断和治疗市场:各地区

  • 简介
  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他
  • 南美
    • 阿根廷
    • 巴西
    • 智利
    • 其他
  • 中东、非洲
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 卡达
    • 南非
    • 其他

第8章 市场主要趋势

  • 收购与合并
  • 协定,伙伴关系,联盟,合资企业
  • 新产品的销售和扩大策略
  • 其他的活动

第9章 企业简介

  • Siemens AG
  • GE Healthcare
  • Medtronic plc
  • Bayer AG
  • Abbott Laboratories
  • Cordis Corporation
  • Boston Scientific Corporation
  • Genentech, Inc.
  • Koninklijke Philips N.V.
  • Stryker Corporation
  • Merck & Co., Inc
  • B. Braun Melsungen AG
  • Teleflex Inc.
  • Cardinal Health
  • Merck Sharp & Dohme Corp.
  • GlaxoSmithKline plc
  • Bristol-Myers Squibb.
  • Boehringer Ingelheim
  • Johnson & Johnson
  • Daiichi Sankyo
目录

According to Stratistics MRC, the Global Stroke Diagnostics and Therapeutics market is accounted for $23,849.39 Million in 2017 and is expected to reach $49,698.68 Million by 2026 growing at a CAGR of 8.5% during the forecast period. Factors such as technological advancement, growing aging population, and people suffering from diabetes are favouring the market. On the other hand, increasing health expenditure, hypertension and also increasing tobacco users are also fuelling the market. However factors such as unfavourable reimbursement scenario and high cost of treatments are hampering the market growth. Stroke is referred to brain attack occurs when there is a holdup in the supply of blood to the brain which leads brain cells to die.

Depending upon Application, Haemorrhagic Stroke is caused on account of the arteries in the brain either leaking blood or bursting open. When it happens, blood collects in the brain tissue. This is toxic for the brain tissue causing the cells in that area to weaken and die. It is one among the cause of death and a leading cause of serious, long-term disability across the world.

By Geography, stroke diagnostics and therapeutics market in Asia is expected to witness the high growth rate in and expected to remain top among other regions in the forecast period due to growing aging population, evolving R&D activities for drug discovery and development, increasing government support in the form of funding and developing healthcare infrastructure in the region. In addition, growing demographics and economies in the developing countries such as India, China, and Japan are expected to lead the growth in the stroke diagnostics and therapeutics market in Asia.

Some of the key players diagnostics and therapeutics market include are Siemens AG, GE Healthcare, Medtronic plc, Bayer AG, Abbott Laboratories, Cordis Corporation, Boston Scientific Corporation, Genentech, Inc., Koninklijke Philips N.V., Stryker Corporation, Merck & Co., Inc, B. Braun Melsungen AG, Teleflex Inc., Cardinal Health, Merck Sharp & Dohme Corp., GlaxoSmithKline plc, Bristol-Myers Squibb., Boehringer Ingelheim, Johnson & Johnson and Daiichi Sankyo.

Types Covered:

  • Diagnostics
  • Therapeutics

Applications Covered:

  • Haemorrhagic Stroke
  • Ischemic Stroke

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country level segments
  • Market share analysis of the top industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Futuristic Market Scenario

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Stroke Diagnostics and Therapeutics Market, By Type

  • 5.1 Introduction
  • 5.2 Diagnostics
    • 5.2.1 Magnetic Resonance Imaging (MRI)
    • 5.2.2 Computed Tomography Scan (CT scan)
    • 5.2.3 Electrocardiography
    • 5.2.4 Carotid Ultrasound
    • 5.2.5 Cerebral Angiography
    • 5.2.6 Other Diagnostics
  • 5.3 Therapeutics
    • 5.3.1 Tissue Plasminogen Activator
    • 5.3.2 Antiplatelet
    • 5.3.3 Antihypertensive
    • 5.3.4 Anticoagulant

6 Global Stroke Diagnostics and Therapeutics Market, By Application

  • 6.1 Introduction
  • 6.2 Haemorrhagic Stroke
  • 6.3 Ischemic Stroke

7 Global Stroke Diagnostics and Therapeutics Market, By Geography

  • 7.1 Introduction
  • 7.2 North America
    • 7.2.1 US
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 Italy
    • 7.3.4 France
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 Japan
    • 7.4.2 China
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 New Zealand
    • 7.4.6 South Korea
    • 7.4.7 Rest of Asia Pacific
  • 7.5 South America
    • 7.5.1 Argentina
    • 7.5.2 Brazil
    • 7.5.3 Chile
    • 7.5.4 Rest of South America
  • 7.6 Middle East & Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 UAE
    • 7.6.3 Qatar
    • 7.6.4 South Africa
    • 7.6.5 Rest of Middle East & Africa

8 Key Developments

  • 8.1 Acquisitions & Mergers
  • 8.2 Agreements, Partnerships, Collaborations and Joint Ventures
  • 8.3 Product Launch & Expansions
  • 8.4 Other Activities

9 Company Profiling

  • 9.1 Siemens AG
  • 9.2 GE Healthcare
  • 9.3 Medtronic plc
  • 9.4 Bayer AG
  • 9.5 Abbott Laboratories
  • 9.6 Cordis Corporation
  • 9.7 Boston Scientific Corporation
  • 9.8 Genentech, Inc.
  • 9.9 Koninklijke Philips N.V.
  • 9.10 Stryker Corporation
  • 9.11 Merck & Co., Inc
  • 9.12 B. Braun Melsungen AG
  • 9.13 Teleflex Inc.
  • 9.14 Cardinal Health
  • 9.15 Merck Sharp & Dohme Corp.
  • 9.16 GlaxoSmithKline plc
  • 9.17 Bristol-Myers Squibb.
  • 9.18 Boehringer Ingelheim
  • 9.19 Johnson & Johnson
  • 9.20 Daiichi Sankyo

List of Tables

  • Table 1 Global Stroke Diagnostics and Therapeutics Market Outlook, By Region (2016-2026) ($MN)
  • Table 2 Global Stroke Diagnostics and Therapeutics Market Outlook, By Type (2016-2026) ($MN)
  • Table 3 Global Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2016-2026) ($MN)
  • Table 4 Global Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2016-2026) ($MN)
  • Table 5 Global Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan) (2016-2026) ($MN)
  • Table 6 Global Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2016-2026) ($MN)
  • Table 7 Global Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2016-2026) ($MN)
  • Table 8 Global Stroke Diagnostics and Therapeutics Market Outlook, By Cerebral Angiography (2016-2026) ($MN)
  • Table 9 Global Stroke Diagnostics and Therapeutics Market Outlook, By Others (2016-2026) ($MN)
  • Table 10 Global Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics (2016-2026) ($MN)
  • Table 11 Global Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2016-2026) ($MN)
  • Table 12 Global Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet (2016-2026) ($MN)
  • Table 13 Global Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive (2016-2026) ($MN)
  • Table 14 Global Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant (2016-2026) ($MN)
  • Table 15 Global Stroke Diagnostics and Therapeutics Market Outlook, By Application (2016-2026) ($MN)
  • Table 16 Global Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2014-2022) ($MN)
  • Table 17 Global Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke (2016-2026) ($MN)
  • Table 18 North America Stroke Diagnostics and Therapeutics Market Outlook, By Type (2016-2026) ($MN)
  • Table 19 North America Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2016-2026) ($MN)
  • Table 20 North America Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2016-2026) ($MN)
  • Table 21 North America Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan) (2016-2026) ($MN)
  • Table 22 North America Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2016-2026) ($MN)
  • Table 23 North America Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2016-2026) ($MN)
  • Table 24 North America Stroke Diagnostics and Therapeutics Market Outlook, By Cerebral Angiography (2016-2026) ($MN)
  • Table 25 North America Stroke Diagnostics and Therapeutics Market Outlook, By Others (2016-2026) ($MN)
  • Table 26 North America Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics (2016-2026) ($MN)
  • Table 27 North America Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2016-2026) ($MN)
  • Table 28 North America Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet (2016-2026) ($MN)
  • Table 29 North America Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive (2016-2026) ($MN)
  • Table 30 North America Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant (2016-2026) ($MN)
  • Table 31 North America Stroke Diagnostics and Therapeutics Market Outlook, By Application (2016-2026) ($MN)
  • Table 32 North America Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2014-2022) ($MN)
  • Table 33 North America Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke (2016-2026) ($MN)
  • Table 34 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Type (2016-2026) ($MN)
  • Table 35 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2016-2026) ($MN)
  • Table 36 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2016-2026) ($MN)
  • Table 37 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan) (2016-2026) ($MN)
  • Table 38 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2016-2026) ($MN)
  • Table 39 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2016-2026) ($MN)
  • Table 40 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Cerebral Angiography (2016-2026) ($MN)
  • Table 41 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Others (2016-2026) ($MN)
  • Table 42 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics (2016-2026) ($MN)
  • Table 43 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2016-2026) ($MN)
  • Table 44 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet (2016-2026) ($MN)
  • Table 45 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive (2016-2026) ($MN)
  • Table 46 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant (2016-2026) ($MN)
  • Table 47 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Application (2016-2026) ($MN)
  • Table 48 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2014-2022) ($MN)
  • Table 49 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke (2016-2026) ($MN)
  • Table 50 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Type (2016-2026) ($MN)
  • Table 51 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2016-2026) ($MN)
  • Table 52 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2016-2026) ($MN)
  • Table 53 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan) (2016-2026) ($MN)
  • Table 54 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2016-2026) ($MN)
  • Table 55 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2016-2026) ($MN)
  • Table 56 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Cerebral Angiography (2016-2026) ($MN)
  • Table 57 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Others (2016-2026) ($MN)
  • Table 58 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics (2016-2026) ($MN)
  • Table 59 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2016-2026) ($MN)
  • Table 60 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet (2016-2026) ($MN)
  • Table 61 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive (2016-2026) ($MN)
  • Table 62 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant (2016-2026) ($MN)
  • Table 63 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Application (2016-2026) ($MN)
  • Table 64 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2014-2022) ($MN)
  • Table 65 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke (2016-2026) ($MN)
  • Table 66 South America Stroke Diagnostics and Therapeutics Market Outlook, By Type (2016-2026) ($MN)
  • Table 67 South America Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2016-2026) ($MN)
  • Table 68 South America Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2016-2026) ($MN)
  • Table 69 South America Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan) (2016-2026) ($MN)
  • Table 70 South America Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2016-2026) ($MN)
  • Table 71 South America Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2016-2026) ($MN)
  • Table 72 South America Stroke Diagnostics and Therapeutics Market Outlook, By Cerebral Angiography (2016-2026) ($MN)
  • Table 73 South America Stroke Diagnostics and Therapeutics Market Outlook, By Others (2016-2026) ($MN)
  • Table 74 South America Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics (2016-2026) ($MN)
  • Table 75 South America Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2016-2026) ($MN)
  • Table 76 South America Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet (2016-2026) ($MN)
  • Table 77 South America Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive (2016-2026) ($MN)
  • Table 78 South America Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant (2016-2026) ($MN)
  • Table 79 South America Stroke Diagnostics and Therapeutics Market Outlook, By Application (2016-2026) ($MN)
  • Table 80 South America Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2014-2022) ($MN)
  • Table 81 South America Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke (2016-2026) ($MN)
  • Table 82 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Type (2016-2026) ($MN)
  • Table 83 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2016-2026) ($MN)
  • Table 84 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2016-2026) ($MN)
  • Table 85 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan) (2016-2026) ($MN)
  • Table 86 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2016-2026) ($MN)
  • Table 87 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2016-2026) ($MN)
  • Table 88 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Cerebral Angiography (2016-2026) ($MN)
  • Table 89 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Others (2016-2026) ($MN)
  • Table 90 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics (2016-2026) ($MN)
  • Table 91 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2016-2026) ($MN)
  • Table 92 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet (2016-2026) ($MN)
  • Table 93 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive (2016-2026) ($MN)
  • Table 94 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant (2016-2026) ($MN)
  • Table 95 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Application (2016-2026) ($MN)
  • Table 96 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2014-2022) ($MN)
  • Table 97 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke (2016-2026) ($MN)